|
Prescription Drug Search
Strengths available for Treanda vial:
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Treanda:
- Albania
- Anguilla
- Bahamas
- Bahrain
- Belize
- Bosnia and Herzegovina
- China
- Croatia
- Cyprus
- Dominican Republic
- European Union
- Finland
- Gibraltar
- Greenland
- Grenada
- Guadeloupe
- India
- Italy
- Korea, Republic of
- Korea, South
- Lebanon
- Liechtenstein
- Lithuania
- Mauritius
- Moldova, Republic of
- Nicaragua
- Panama
- Paraguay
- Peru
- Poland
- Qatar
- Romania
- South Africa
- Sri Lanka
- Tunisia
- Turkey
- United Kingdom, UK
- United States, US
- Uruguay
- Vietnam
Latest news releases on Treanda:
Teva reduces 2012 sales forecast - Marketwatch
The reduced forecast for branded drugs includes its outlook for leukemia drug Treanda and its women's health products. Teva recently reported its first-quarter profit jumped 41%, as strong sales of branded and generic medicines in the U.S. and ...
Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40 - StreetInsider.com
Brand product net sales of approximately $8.0 billion including estimated global net sales of the following products: -- COPAXONE® of $3.8 billion-- TREANDA® of $580 million-- Women’s Health products of $500 million-- ProAir® HFA of $430 million ...
Mixed Quarter from Teva - Yahoo Finance
Revenues benefited from the inclusion of Cephalon products – Provigil ($291 million), Treanda ($148 million) and Nuvigil ($84 million). Key branded product Copaxone posted global in-market sales of $941 billion, up 4%. Other products/segments ...
Strong growth at Teva as Yanai era ends - Chicago Tribune
The increase in branded products revenue was mainly due to the inclusion of Cephalon sales (mainly Provigil with $291 million in revenue, Treanda with $148 million and Nuvigil with $84 million). Most of Teva's major branded products also had strong revenue.
